ROLE OF EARLY REPERFUSION IN THE INDUCTION OF ADHESION MOLECULES AND CYTOKINES IN PREVIOUSLY ISCHEMIC MYOCARDIUM

被引:63
作者
KUKIELKA, GL
YOUKER, KA
MICHAEL, LH
KUMAR, AG
BALLANTYNE, CM
SMITH, CW
ENTMAN, ML
机构
[1] TEXAS CHILDRENS HOSP,BAYLOR COLL MED,CARDIOVASC SCI SECT,HOUSTON,TX 77030
[2] METHODIST HOSP,DEPT MED,CARDIOVASC SCI SECT,HOUSTON,TX 77030
[3] BAYLOR COLL MED,DEBAKEY HEART CTR,SPEROS P MARTEL SECT LEUKOCYTE BIOL,DEPT PEDIAT,HOUSTON,TX 77030
关键词
MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL INFARCTION; INTERLEUKIN-6; INTERLEUKIN-8; CELL ADHESION MOLECULES; NEUTROPHILS;
D O I
10.1007/BF00944777
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Our studies in vitro demonstrate that neutrophil mediated injury of isolated cardiac myocytes requires the presence of ICAM-1 on the surface of the myocyte and CD11b/CD18 activation on the neutrophil. In post-ischemic cardiac lymph, there is rapid appearance of C5a activity during the first hours of reperfusion. Interleukin-6 activity is present throughout the first 72 h of reperfusion and is sufficient to induce ICAM-1 on the surface of the cardiac myocyte. In situ hybridization studies suggest that ICAM-1 mRNA is found in viable myocardial cells on the edge of the myocardial infarction within 1 h of reperfusion. ICAM-1 protein expression on cardiac myocytes is seen after 6 h of reperfusion, and increases thereafter. Non-ischemic tissue demonstrates no early induction of ICAM-1 mRNA or ICAM-1 protein on myocardial cells. In our most recent experiments, we have determined that reperfusion is an absolute requirement for the early induction of myocardial ICAM-1 mRNA in previously ischemic myocardial cells. To further assess this, we have cloned and sequenced a canine interleukin-6 (IL-6) cDNA. The data suggest that early induction of IL-6 mRNA is also reperfusion dependent as it could be demonstrated in the same ischemic and reperfused segments in which ICAM-1 mRNA was found. Peak expression of IL-6 mRNA occurred much earlier than that for ICAM-1 mRNA. Similar experiments were then performed with a molecular probe for interleukin-8 (IL-8). This chemokine is a potent neutrophil stimulant and has a higher degree of specificity for neutrophils than classic chemoattractants such as C5a. The results suggest a similar pattern of induction that occurs within the first hour and is markedly increased by reperfusion. The relationship of reperfusion to ICAM-1 and cytokine induction is discussed.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 42 条
[1]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[2]  
BAGGIOLINI M, 1992, INFLAMMATION BASIC P, P247
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   COMPLEMENT AND NEUTROPHIL ACTIVATION IN THE PATHOGENESIS OF ISCHEMIC MYOCARDIAL INJURY [J].
CRAWFORD, MH ;
GROVER, FL ;
KOLB, WP ;
MCMAHAN, CA ;
OROURKE, RA ;
MCMANUS, LM ;
PINCKARD, RN .
CIRCULATION, 1988, 78 (06) :1449-1458
[5]   CANINE NEUTROPHIL ACTIVATION BY CARDIAC LYMPH OBTAINED DURING REPERFUSION OF ISCHEMIC MYOCARDIUM [J].
DREYER, WJ ;
SMITH, CW ;
MICHAEL, LH ;
ROSSEN, RD ;
HUGHES, BJ ;
ENTMAN, ML ;
ANDERSON, DC .
CIRCULATION RESEARCH, 1989, 65 (06) :1751-1762
[6]   NEUTROPHIL ACCUMULATION IN ISCHEMIC CANINE MYOCARDIUM - INSIGHTS INTO TIME COURSE, DISTRIBUTION, AND MECHANISM OF LOCALIZATION DURING EARLY REPERFUSION [J].
DREYER, WJ ;
MICHAEL, LH ;
WEST, MS ;
SMITH, CW ;
ROTHLEIN, R ;
ROSSEN, RD ;
ANDERSON, DC ;
ENTMAN, ML .
CIRCULATION, 1991, 84 (01) :400-411
[7]  
EMBER JA, 1994, AM J PATHOL, V144, P393
[8]   NEUTROPHIL INDUCED OXIDATIVE INJURY OF CARDIAC MYOCYTES - A COMPARTMENTED SYSTEM REQUIRING CD11B CD18-ICAM-1 ADHERENCE [J].
ENTMAN, ML ;
YOUKER, K ;
SHOJI, T ;
KUKIELKA, G ;
SHAPPELL, SB ;
TAYLOR, AA ;
SMITH, CW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1335-1345
[9]   NEUTROPHIL ADHERENCE TO ISOLATED ADULT CANINE MYOCYTES - EVIDENCE FOR A CD18-DEPENDENT MECHANISM [J].
ENTMAN, ML ;
YOUKER, K ;
SHAPPELL, SB ;
SIEGEL, C ;
ROTHLEIN, R ;
DREYER, WJ ;
SCHMALSTIEG, FC ;
SMITH, CW .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1497-1506
[10]  
ENTMAN ML, 1993, HDB IMMUNOPHARMACOLO, P55